47 related articles for article (PubMed ID: 19034038)
1. In vivo arrhythmogenicity of the marine biotoxin azaspiracid-2 in rats.
Ferreiro SF; Vilariño N; Carrera C; Louzao MC; Santamarina G; Cantalapiedra AG; Rodríguez LP; Cifuentes JM; Vieira AC; Nicolaou KC; Frederick MO; Botana LM
Arch Toxicol; 2014 Feb; 88(2):425-34. PubMed ID: 23934164
[TBL] [Abstract][Full Text] [Related]
2. Cell-Free Synthesis and Electrophysiological Analysis of Multipass Voltage-Gated Ion Channels Tethered in Microsomal Membranes.
Pandey Y; Dondapati SK; Wüstenhagen D; Kubick S
Adv Biochem Eng Biotechnol; 2023; 186():103-120. PubMed ID: 37640910
[TBL] [Abstract][Full Text] [Related]
3. Calculations of the binding free energies of the Comprehensive
Negami T; Terada T
Biophys Physicobiol; 2023; 20(2):e200016. PubMed ID: 38496247
[TBL] [Abstract][Full Text] [Related]
4. hERG K(+) channels: structure, function, and clinical significance.
Vandenberg JI; Perry MD; Perrin MJ; Mann SA; Ke Y; Hill AP
Physiol Rev; 2012 Jul; 92(3):1393-478. PubMed ID: 22988594
[TBL] [Abstract][Full Text] [Related]
5. Sigma non-opioid receptor 1 is a potential therapeutic target for long QT syndrome.
Song L; Bekdash R; Morikawa K; Quejada JR; Klein AD; Aina-Badejo D; Yoshida K; Yamamoto HE; Chalan A; Yang R; Patel A; Sirabella D; Lee TM; Joseph LC; Kawano F; Warren JS; Soni RK; Morrow JP; Yazawa M
Nat Cardiovasc Res; 2022 Feb; 1(2):142-156. PubMed ID: 36051854
[TBL] [Abstract][Full Text] [Related]
6. Opioids and Cardiac Arrhythmia: A Literature Review.
Behzadi M; Joukar S; Beik A
Med Princ Pract; 2018; 27(5):401-414. PubMed ID: 30071529
[TBL] [Abstract][Full Text] [Related]
7. Natural products modulating the hERG channel: heartaches and hope.
Kratz JM; Grienke U; Scheel O; Mann SA; Rollinger JM
Nat Prod Rep; 2017 Aug; 34(8):957-980. PubMed ID: 28497823
[TBL] [Abstract][Full Text] [Related]
8. Automated electrophysiology makes the pace for cardiac ion channel safety screening.
Möller C; Witchel H
Front Pharmacol; 2011; 2():73. PubMed ID: 22131974
[TBL] [Abstract][Full Text] [Related]
9. The cardiac hERG/IKr potassium channel as pharmacological target: structure, function, regulation, and clinical applications.
Thomas D; Karle CA; Kiehn J
Curr Pharm Des; 2006; 12(18):2271-83. PubMed ID: 16787254
[TBL] [Abstract][Full Text] [Related]
10. Collation, assessment and analysis of literature in vitro data on hERG receptor blocking potency for subsequent modeling of drugs' cardiotoxic properties.
Polak S; Wiśniowska B; Brandys J
J Appl Toxicol; 2009 Apr; 29(3):183-206. PubMed ID: 18988205
[TBL] [Abstract][Full Text] [Related]
11. Effects of common antitussive drugs on the hERG potassium channel current.
Deisemann H; Ahrens N; Schlobohm I; Kirchhoff C; Netzer R; Möller C
J Cardiovasc Pharmacol; 2008 Dec; 52(6):494-9. PubMed ID: 19034038
[TBL] [Abstract][Full Text] [Related]
12. In silico prediction of the chemical block of human ether-a-go-go-related gene (hERG) K+ current.
Inanobe A; Kamiya N; Murakami S; Fukunishi Y; Nakamura H; Kurachi Y
J Physiol Sci; 2008 Dec; 58(7):459-70. PubMed ID: 19032804
[TBL] [Abstract][Full Text] [Related]
13. Simulation of multiple ion channel block provides improved early prediction of compounds' clinical torsadogenic risk.
Mirams GR; Cui Y; Sher A; Fink M; Cooper J; Heath BM; McMahon NC; Gavaghan DJ; Noble D
Cardiovasc Res; 2011 Jul; 91(1):53-61. PubMed ID: 21300721
[TBL] [Abstract][Full Text] [Related]
14. High-throughput screening of drug-binding dynamics to HERG improves early drug safety assessment.
Di Veroli GY; Davies MR; Zhang H; Abi-Gerges N; Boyett MR
Am J Physiol Heart Circ Physiol; 2013 Jan; 304(1):H104-17. PubMed ID: 23103500
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
